Allergan Agrees To $219 A Share Actavis Takeover Over Bill Ackman-Backed Valeant Deal

Botox-maker Allergan has agreed to be sold to generic pharmaceutical manufacturer Actavis for $219 a share in cash and stock.

Source: Forbes.com Healthcare News - November 17, 2014 Category: Pharmaceuticals Authors: Antoine Gara Source Type: news